April 23, 2018 by Chain Drug Review
ACA, Centers for Medicaid and Medicare Services, CMS
Issue 04-23-2018, News
WASHINGTON — The Trump administration has shifted more control over the Affordable Care Act marketplaces to the states and given consumers more leeway to avoid participation this year. A new final rule issued recently by the Centers for Medicare and Medicaid Services (CMS) relaxes certain regulations regarding ACA health plans in order to drive competition
March 13, 2017 by Mark Baumgartner and Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, health expenditures in the United States, U.S. health care spending
2017, Issue 03-13-2017, Issues, News
WASHINGTON — The pace of growth in U.S. health care spending is expected to quicken this year, increasing 5.4% over 2016, according to a report by the Centers for Medicare & Medicaid Services (CMS). Health care spending last year hit $3.4 trillion, an amount that represents a 4.8% increase from 2015, CMS said in a
January 2, 2017 by Greg Jacobson and Chain Drug Review
Affordable Care Act, Andy Slavitt, Centers for Medicare & Medicaid Services, CMS, spending for prescription drugs, U.S. health care spending
2017, Issue 01-02-2017, Issues, News
WASHINGTON — Health care spending in the United States grew 5.8% to $3.2 trillion during 2015, according to a new study by the Centers for Medicare & Medicaid Services (CMS). On a per capita basis, U.S. health care spending grew 5% to $9,990 per person. The overall increase exceeded the 5.5% rise projected by CMS
December 12, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, Department of Health and Human Services, Donald Trump, HHS, National Association of Chain Drug Stores, Obamacare, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — The choices of Tom Price and Seema Verma for top health positions under Donald Trump have reaffirmed the president-elect’s commitment to toppling the Affordable Care Act. Price, a six-term Republican congressman from Georgia and fierce critic of Obamacare, was picked as secretary of the Department of Health and Human Services (HHS), while Verma,
July 25, 2016 by Greg Jacobson and Chain Drug Review
Centers for Medicare & Medicaid Services, CMS, health care spending in the United States, National Health Expenditure Projections 2015–25, Sean Keehan
2016, Issue 07-25-2016, Issues, News
WASHINGTON — A new study by personnel of the Centers for Medicare & Medicaid Services (CMS) projects that health care spending in the United States will exceed $10,000 per person this year. The report, published in the health policy journal Health Affairs, predicts that health care spending growth is accelerating after several years of unusually
June 22, 2016 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, CMS, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News

ALEXANDRIA, Va. — Nearly 50 members of Congress have called on the Centers for Medicare & Medicaid Services (CMS) to finalize its proposed guidance on how Medicare Part D sponsors report pharmacy price concessions, also known as direct and indirect remuneration (DIR) fees. The National Community Pharmacists Association said that 16 senators and 30 representatives
May 19, 2016 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, CMS, DIR fees, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News

ALEXANDRIA, Va. — The National Community Pharmacists Association has joined with a group of pharmacy industry stakeholders in calling for more clarity about direct and indirect (DIR) fees. NCPA said that this week it teamed up with 21 other organizations — including drug chains, drug suppliers, drug cooperatives and pharmacy associations, among others — in
April 27, 2016 by Chain Drug Review
Center for Medicare & Medicaid Services, Children’s Health Insurance Program, CHIP, CMS, managed care final rule, Medicaid, NACDS, National Association of Chain Drug Stores, Steve Anderson
Leading Headlines, Pharmacy, Retail News

ARLINGTON, Va. – The National Association of Chain Drug Stores hailed the Center for Medicare & Medicaid Services’ inclusion of network adequacy standards in the Medicaid and CHIP Managed Care final rule. NACDS said Wednesday that the final rule, released on April 21, would improve patient access to care in Medicaid and the Children’s Health
March 8, 2016 by CDR Blog
Centers for Medicare & Medicaid Services, CMS, Covered Outpatient Drugs final rule, final AMP-based FULs, Medicaid Drug Rebate Program, Medicaid drug reimbursement, NACDS, National Association of Chain Drug Stores
CDR Blog

The National Association of Chain Drug Stores reports that final average manufacturer price (AMP)-based federal upper limits (FULs) are set to be published by the Centers for Medicare & Medicaid Services (CMS) late this month. Once instituted, the final AMP-based FULs will “significantly change” Medicaid pharmacy reimbursement for branded and generic drugs, according to NACDS.
February 26, 2016 by CDR Blog
Centers for Medicare & Medicaid Services, CMS, Medicare Part D, National Community Pharmacists Association, NCPA, prescription drug plans
CDR Blog

The National Community Pharmacists Association has given a rundown of what it described as a “wide-ranging” 228-page call letter by the Centers for Medicare & Medicaid Services (CMS) concerning proposed revisions to Medicare Part D prescription drug plans in 2017. In a blog post this week, NCPA outlined some of the key changes that community
February 12, 2016 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, CMS, Medicare Part D, National Community Pharmacists Association, NCPA, preferred pharmacies, Sean Cavanaugh
Featured Articles, Leading Headlines, Pharmacy, Retail News

ALEXANDRIA, Va. — Though the Centers for Medicare & Medicaid Services (CMS) has improved Medicare Part D patient access to preferred pharmacies, more work needs to be done, according to the National Community Pharmacists Association. NCPA on Friday applauded a statement released by CMS that the agency’s efforts to boost access to preferred pharmacies across
February 8, 2016 by Geoff Walden and Chain Drug Review
Affordable Care Act, AMP, AMP definition, average manufacturer price, B. Douglas Hoey, Centers for Medicare & Medicaid Services, CMS, Federal Upper Limit, FUL, Healthcare Distribution Management Association, John Gray, Medicaid prescription reimbursements, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, pharmacy reimbursements, Steve Anderson
2016, Issue 02-08-2016, Issues, News

ARLINGTON, Va. — The National Association of Chain Drug Stores was working with member companies at presstime to review the final rule on Medicaid prescription reimbursements. The Centers for Medicare & Medicaid Services (CMS) says the 658-page rule — which takes effect April 1 after a comment period — establishes a regulatory definition for average
February 8, 2016 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, AMP, average manufacturer prices, Centers for Medicare & Medicaid Services, CMS, Covered Outpatient Drugs, federal upper limits, FULs, Jeffrey Woldt, Medicaid, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, pharmacy reimbursement, Steve Anderson
2016, Issue 02-08-2016, Issues, Leading Headlines, Opinion

After years of political and legal wrangling, the Centers for Medicare & Medicaid Services (CMS) has issued its final rule on Covered Outpatient Drugs, which governs reimbursement to retail pharmacies for generic medications dispensed under Medicaid. The history of the regulation goes all the way back to the Deficit Reduction Act of 2005 (DRA), which
December 10, 2015 by Chain Drug Review
Centers for Medicare & Medicaid Services, CMS, Medicare Part D, Publix, Publix Pharmacy, video
Videos

With many seniors moving to new Medicare Part D coverage for next year, Publix Super Markets is urging them to switch their prescriptions to its pharmacies. An online video posted this week by the food and drug chain notes that Publix Pharmacy is a preferred pharmacy in a number of insurance plans, so Part D recipients could save more on